Cargando…
Exploiting nanotechnology to target cancer
Nanotechnology is increasingly finding use in the management of cancer. Nanoscale devices have impacted cancer biology at three levels: early detection using, for example, nanocantilevers or nanoparticles; tumour imaging using radiocontrast nanoparticles or quantum dots; and drug delivery using nano...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360169/ https://www.ncbi.nlm.nih.gov/pubmed/17406364 http://dx.doi.org/10.1038/sj.bjc.6603707 |
_version_ | 1782152981466054656 |
---|---|
author | Sengupta, S Sasisekharan, R |
author_facet | Sengupta, S Sasisekharan, R |
author_sort | Sengupta, S |
collection | PubMed |
description | Nanotechnology is increasingly finding use in the management of cancer. Nanoscale devices have impacted cancer biology at three levels: early detection using, for example, nanocantilevers or nanoparticles; tumour imaging using radiocontrast nanoparticles or quantum dots; and drug delivery using nanovectors and hybrid nanoparticles. This review addresses some of the major milestones in the integration of nanotechnology and cancer biology, and the future of nanoscale approaches for cancer management. |
format | Text |
id | pubmed-2360169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23601692009-09-10 Exploiting nanotechnology to target cancer Sengupta, S Sasisekharan, R Br J Cancer Review Nanotechnology is increasingly finding use in the management of cancer. Nanoscale devices have impacted cancer biology at three levels: early detection using, for example, nanocantilevers or nanoparticles; tumour imaging using radiocontrast nanoparticles or quantum dots; and drug delivery using nanovectors and hybrid nanoparticles. This review addresses some of the major milestones in the integration of nanotechnology and cancer biology, and the future of nanoscale approaches for cancer management. Nature Publishing Group 2007-05-07 2007-04-03 /pmc/articles/PMC2360169/ /pubmed/17406364 http://dx.doi.org/10.1038/sj.bjc.6603707 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Sengupta, S Sasisekharan, R Exploiting nanotechnology to target cancer |
title | Exploiting nanotechnology to target cancer |
title_full | Exploiting nanotechnology to target cancer |
title_fullStr | Exploiting nanotechnology to target cancer |
title_full_unstemmed | Exploiting nanotechnology to target cancer |
title_short | Exploiting nanotechnology to target cancer |
title_sort | exploiting nanotechnology to target cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360169/ https://www.ncbi.nlm.nih.gov/pubmed/17406364 http://dx.doi.org/10.1038/sj.bjc.6603707 |
work_keys_str_mv | AT senguptas exploitingnanotechnologytotargetcancer AT sasisekharanr exploitingnanotechnologytotargetcancer |